INS and diabetes mellitus: In both experimental groups, the toxic effect of STZ was present, and the high dose of STZ destroys the insulin-producers beta cells, leading to acute nonimmune-mediated diabetes; in contrast the multiple low doses of STZ at 40 mg/Kg, daily for five consecutive days, require participation of immune-inflammatory events for T1DM development [41].